Pablo Mir Rivera-rekin lankidetzan egindako argitalpenak (8)

2023

  1. Staging Parkinson's Disease According to the MNCD (Motor/Non-motor/Cognition/Dependency) Classification Correlates with Disease Severity and Quality of Life

    Journal of Parkinson's disease, Vol. 13, Núm. 3, pp. 379-402

2022

  1. Genetic landscape of Segawa disease in Spain. Long-term treatment outcomes

    Parkinsonism and Related Disorders, Vol. 94, pp. 67-78

2021

  1. Management of Parkinson's disease and other movement disorders in woman of childbearing age: Part 1

    Neurologia, Vol. 36, Núm. 2, pp. 149-158

  2. Management of Parkinson's disease and other movement disorders in women of childbearing age: Part 2

    Neurologia, Vol. 36, Núm. 2, pp. 159-168

  3. Spanish expert consensus on the use of safinamide in Parkinson's disease

    Neurologia, Vol. 36, Núm. 9, pp. 666-672

2019

  1. Clinical and genetic characteristics of late-onset Huntington's disease

    Parkinsonism and Related Disorders, Vol. 61, pp. 101-105

  2. Using global team science to identify genetic parkinson's disease worldwide

    Annals of Neurology

2016

  1. COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global -clinical evaluations, serum biomarkers, genetic studies and neuroimaging- prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression

    BMC Neurology, Vol. 16, Núm. 1